Literature DB >> 20014654

Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.

F Benedetti1, D Radaelli, A Bernasconi, S Dallaspezia, C Colombo, E Smeraldi.   

Abstract

Few pilot prospective studies performed BOLD fMRI before and after treatment in order to define the neural correlates of antidepressant response. To determine how antidepressant treatment influences the pattern of neural response to a task targeting the depressive biases in information processing (moral valence decision), eight depressed inpatients were treated with combined venlafaxine and light therapy for four weeks. Brain BOLD functional magnetic resonance imaging on a 3.0 Tesla scanner was performed before and after treatment. Treatment and moral value of the stimuli showed the most significant interaction in right medial frontal gyrus (BA 10), where also clinical status was found to be inversely correlated with response to negative stimuli after treatment. A significant interaction of treatment and valence of the stimuli was also detected in other areas that have been widely associated with the depressive illness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20014654

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  5 in total

1.  Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.

Authors:  Francesco Benedetti; Sara Poletti; Thomas A Hoogenboezem; Clara Locatelli; Oliver Ambrée; Harm de Wit; Annemarie J M Wijkhuijs; Elena Mazza; Chiara Bulgarelli; Benedetta Vai; Cristina Colombo; Enrico Smeraldi; Volker Arolt; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

2.  The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation.

Authors:  Gabriel S Dichter; Jennifer N Felder; Moria J Smoski
Journal:  J Affect Disord       Date:  2010-04-24       Impact factor: 4.839

3.  Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder.

Authors:  Francesco Benedetti; Mariagrazia Palladini; Greta D'Orsi; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Mario Gennaro Mazza
Journal:  J Affect Disord       Date:  2022-04-20       Impact factor: 6.533

Review 4.  Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hirofumi Hirakawa; Takeshi Terao; Masaaki Muronaga; Nobuyoshi Ishii
Journal:  Brain Behav       Date:  2020-10-09       Impact factor: 2.708

Review 5.  Brain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective Processing.

Authors:  Michèle Wessa; Giannis Lois
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.